SHANGHAI – Alphamab Oncology Co. Ltd. now has more than $100 million in its coffers to push its four top antibody candidates through the clinic in China, the U.S., Japan and Australia for the next two years. The series A financing came from venture investors Advantech Capital, PAG, China Venture Capital Fund, Orbimed, Heritage Provider Network and Janchor Partners. Read More
HONG KONG – Denovo Biopharma LLC, a cross-border biotech registered in San Diego and Hangzhou, China, has been granted IND approval by Chinese regulators to conduct international multicenter clinical trials for its neuroscience drug, DB-103 (pomaglumetad). If successful, DB-103 could prove a heavyweight product in the schizophrenia space. Read More
HONG KONG – The Indian government reportedly made moves in late October to prevent the rupee from falling further against the U.S. dollar. While the Indian currency is expected to benefit from the proposed plan, local pharmaceutical firms are likely to suffer from a stronger rupee. Read More
PERTH, Australia – Australia is rolling out a nationwide electronic health record (EHR) portal, called My Health Record under which patients will be able to access their health data any time and take the information with them when they move. Read More
Sinclair Pharma Ltd., of London, closed its acquisition by Huadong Medicine Co. Ltd., of Hangzhou, China, for approximately $222 million. Sinclair will continue to operate as a stand-alone company under the leadership of current CEO Chris Spooner. Read More
Immuron Ltd., of Melbourne, Australia, appointed Gary S. Jacob CEO. Jacob is the former chairman, president and CEO of Synergy Pharmaceuticals Inc. Read More
